Nature Cancer (@natcancer.nature.com)

🚨 Clinical Trial published at Nature Cancer! David Cibula and colleagues report on the final outcome of the SENTIX international trial, assessing sentinel LN biopsy without systematic pelvic lymphadenectomy in early-stage cervical cancer. 🔗 www.nature.com/articles/s43...

loading . . .

Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international tri... Cibula et al. present survival results of the SENTIX trial and demonstrate that SLN biopsy alone does not increase the risk of disease recurrence in patients with early-stage cervical cancer. https://www.nature.com/articles/s43018-025-01016-y?utm_source=bluesky&utm_medium=social&utm_campaign=natcancer